- Home
- GREE vs ATHE Comparison
GREE vs ATHE Comparison
Compare GREE & ATHE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GREE
- ATHE
- Stock Information
- Founded
- GREE 1937
- ATHE 1997
- Country
- GREE United States
- ATHE Australia
- Employees
- GREE N/A
- ATHE N/A
- Industry
- GREE Investment Bankers/Brokers/Service
- ATHE Biotechnology: Pharmaceutical Preparations
- Sector
- GREE Finance
- ATHE Health Care
- Exchange
- GREE Nasdaq
- ATHE Nasdaq
- Market Cap
- GREE 23.4M
- ATHE 21.4M
- IPO Year
- GREE N/A
- ATHE N/A
- Fundamental
- Price
- GREE $1.91
- ATHE $3.42
- Analyst Decision
- GREE Strong Buy
- ATHE Strong Buy
- Analyst Count
- GREE 1
- ATHE 2
- Target Price
- GREE $4.00
- ATHE $6.00
- AVG Volume (30 Days)
- GREE 346.5K
- ATHE 79.3K
- Earning Date
- GREE 11-07-2024
- ATHE 02-15-2025
- Dividend Yield
- GREE N/A
- ATHE N/A
- EPS Growth
- GREE N/A
- ATHE N/A
- EPS
- GREE N/A
- ATHE N/A
- Revenue
- GREE $64,382,999.00
- ATHE $2,681,669.00
- Revenue This Year
- GREE N/A
- ATHE N/A
- Revenue Next Year
- GREE N/A
- ATHE N/A
- P/E Ratio
- GREE N/A
- ATHE N/A
- Revenue Growth
- GREE N/A
- ATHE 2.63
- 52 Week Low
- GREE $1.51
- ATHE $1.00
- 52 Week High
- GREE $5.45
- ATHE $4.71
- Technical
- Relative Strength Index (RSI)
- GREE 52.21
- ATHE 60.87
- Support Level
- GREE $1.51
- ATHE $3.20
- Resistance Level
- GREE $1.92
- ATHE $4.71
- Average True Range (ATR)
- GREE 0.14
- ATHE 0.48
- MACD
- GREE 0.03
- ATHE -0.07
- Stochastic Oscillator
- GREE 75.49
- ATHE 29.12
About GREE Greenidge Generation Holdings Inc.
Greenidge Generation Holdings Inc owns and operates a vertically integrated cryptocurrency data center and power generation company. The company owns and operates facilities at two locations: the Town of Torrey, New York, and Spartanburg, South Carolina. The cryptocurrency data center operations generate revenue in the form of bitcoin by earning bitcoin as rewards and transaction fees for supporting the bitcoin network with application-specific integrated circuit computers (ASICs or miners) owned or leased by the company.
About ATHE Alterity Therapeutics Limited
Alterity Therapeutics Ltd is active in the healthcare domain. The company is engaged in research collaborations for the treatment of Parkinsonian movement disorders, Alzheimer's disease, Huntington disease, and other neurodegenerative disorders. The company's drug candidate-PBT2 is being developed for the treatment of Alzheimer's and Huntington's diseases. It has a drug candidate for Parkinson's disease and other movement disorders (ATH434). The Group operated in one segment, being researching and developing Parkinsonian and other neurodegenerative disorders.